Diagnostic and prognostic nomograms for bone metastasis in small cell lung cancer
- PMID: 34693779
- PMCID: PMC8551427
- DOI: 10.1177/03000605211050735
Diagnostic and prognostic nomograms for bone metastasis in small cell lung cancer
Abstract
Objective: Patients with bone metastasis (BM) of small cell lung cancer (SCLC) have a poor prognosis. We aimed to identify predictors and prognostic factors in patients with BM of SCLC and construct nomograms to predict BM.
Methods: We retrospectively analyzed 18,187 cases from the Surveillance, Epidemiology, and End Results database reported between 2010 and 2016. Differences in overall survival (OS) and cancer-specific survival (CSS) were evaluated after propensity score matching. Independent predictors for BM and prognostic factors for patients with BM of SCLC were determined using univariate and multivariate regression analyses. Two nomograms were constructed and evaluated using C-statistics.
Results: BM was observed in 4014 (22.07%) patients. Kaplan-Meier survival analysis revealed significant differences between BM and non-BM groups. The median OS for patients with and without BM was 6 and 7 months, respectively. The median CSS for patients with and without BM was 9 and 13 months, respectively. Age, sex, tumor size, N stage, chemotherapy, surgery, radiotherapy, and liver/brain/lung metastases were related to BM and independent prognostic factors for OS and CSS. Diagnostic and prognostic nomograms were generated.
Conclusion: Our nomograms predicted the incidence of BM and the 5-month survival rate of patients with SCLC and BM.
Keywords: Epidemiology; Small cell lung cancer; Surveillance; and End Results database; bone metastasis; nomogram; predictor; prognosis.
Conflict of interest statement
Figures




Similar articles
-
Prognostic factors in extensive-stage small cell lung cancer patients with organ-specific metastasis: unveiling commonalities and disparities.J Cancer Res Clin Oncol. 2024 Feb 2;150(2):74. doi: 10.1007/s00432-024-05621-9. J Cancer Res Clin Oncol. 2024. PMID: 38305793 Free PMC article.
-
Prognostic Nomograms for Elderly Patients with Small Cell Lung Cancer Brain Metastasis: A Surveillance, Epidemiology, and End Results Population-Based Study with Temporal External Validation.World Neurosurg. 2024 Sep;189:e632-e651. doi: 10.1016/j.wneu.2024.06.137. Epub 2024 Jun 28. World Neurosurg. 2024. PMID: 38945206
-
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.BMC Cancer. 2020 Jun 1;20(1):494. doi: 10.1186/s12885-020-06995-y. BMC Cancer. 2020. PMID: 32487048 Free PMC article.
-
Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.BMC Cancer. 2020 Nov 25;20(1):1145. doi: 10.1186/s12885-020-07635-1. BMC Cancer. 2020. PMID: 33238981 Free PMC article.
-
Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.World J Surg Oncol. 2021 Aug 30;19(1):258. doi: 10.1186/s12957-021-02364-6. World J Surg Oncol. 2021. PMID: 34461929 Free PMC article.
Cited by
-
Machine learning for synchronous bone metastasis risk prediction in high grade lung neuroendocrine carcinoma.Sci Rep. 2025 Jul 9;15(1):24637. doi: 10.1038/s41598-025-09762-w. Sci Rep. 2025. PMID: 40634407 Free PMC article.
-
Role of radiotherapy on long-term outcomes of patients with small cell lung cancer under different metastasis patterns.World J Surg Oncol. 2025 Apr 7;23(1):125. doi: 10.1186/s12957-025-03766-6. World J Surg Oncol. 2025. PMID: 40197230 Free PMC article.
-
Investigation of TMEM41A's function in breast cancer prognosis and its connection to immune cell infiltration.Clin Transl Oncol. 2025 Apr;27(4):1569-1585. doi: 10.1007/s12094-024-03714-y. Epub 2024 Sep 12. Clin Transl Oncol. 2025. PMID: 39264531
-
Harmine loaded Au@MSNs@PEG@Asp6 nano-composites for treatment of spinal metastasis from lung adenocarcinoma by targeting ANXA9 in vivo experiment.Transl Lung Cancer Res. 2023 May 31;12(5):1062-1077. doi: 10.21037/tlcr-23-191. Epub 2023 May 26. Transl Lung Cancer Res. 2023. PMID: 37323183 Free PMC article.
-
Development and validation of a predictive risk tool for VTE in women with breast cancer under chemotherapy: a cohort study in China.Breast Cancer. 2025 Jan;32(1):154-165. doi: 10.1007/s12282-024-01646-7. Epub 2024 Nov 16. Breast Cancer. 2025. PMID: 39549222
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020; 70: 7–30. - PubMed
-
- Bray F, Ferlay J, Soerjomataram I, et al.. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424. - PubMed
-
- Jett JR, Schild SE, Kesler KA, et al.. Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143: e400S–e419S. - PubMed
-
- Fornetti J, Welm AL, Stewart SA. Understanding the Bone in Cancer Metastasis. J Bone Miner Res 2018; 33: 2099–2113. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical